CD24 and neoplasm: Using flow cytometry, CSCs can be distinguished from the bulk of the tumor by their expression of cell surface makers CD44 and CD24 (as a CD44(+)CD24(-/low) subpopulation) and based on the activity of ALDH1 [16].